학술논문
Immunoengineering can overcome the glycocalyx armour of cancer cells
Document Type
Article
Author
Park, Sangwoo; Colville, Marshall J.; Paek, Justin H.; Shurer, Carolyn R.; Singh, Arun; Secor, Erica J.; Sailer, Cooper J.; Huang, Ling-Ting; Kuo, Joe Chin-Hun; Goudge, Marc C.; Su, Jin; Kim, Minsoo; DeLisa, Matthew P.; Neelamegham, Sriram; Lammerding, Jan; Zipfel, Warren R.; Fischbach, Claudia; Reesink, Heidi L.; Paszek, Matthew J.
Source
Nature Materials; March 2024, Vol. 23 Issue: 3 p429-438, 10p
Subject
Language
ISSN
14761122; 14764660
Abstract
Cancer cell glycocalyx is a major line of defence against immune surveillance. However, how specific physical properties of the glycocalyx are regulated on a molecular level, contribute to immune evasion and may be overcome through immunoengineering must be resolved. Here we report how cancer-associated mucins and their glycosylation contribute to the nanoscale material thickness of the glycocalyx and consequently modulate the functional interactions with cytotoxic immune cells. Natural-killer-cell-mediated cytotoxicity is inversely correlated with the glycocalyx thickness of the target cells. Changes in glycocalyx thickness of approximately 10 nm can alter the susceptibility to immune cell attack. Enhanced stimulation of natural killer and T cells through equipment with chimeric antigen receptors can improve the cytotoxicity against mucin-bearing target cells. Alternatively, cytotoxicity can be enhanced through engineering effector cells to display glycocalyx-editing enzymes, including mucinases and sialidases. Together, our results motivate the development of immunoengineering strategies that overcome the glycocalyx armour of cancer cells.